American College of Cardiology

APRIL 18, 2025

Patients who undergo catheter ablation for atrial fibrillation (AFib) who also have heart failure with preserved ejection fraction (HFpEF) experienced a greater benefit from ablation in terms of clinical outcome, AFib recurrence and functional status, according to findings from the CABANA trial.

Preserved Ejection Fraction 75

Preserved Ejection Fraction Ablation AFIB Outcomes 75

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. Circulation.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

Science Daily - Heart Disease

APRIL 22, 2024

Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. This irregular heartbeat is associated with increased risks of heart failure, dementia and stroke. It gives early warnings on average 30 minutes before onset, with an accuracy of around 80%.

Arrhythmia 124

Arrhythmia Atrial Fibrillation Dementia Heart Failure 124

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

Initial causality was assessed by inverse variance weighting (IVW), followed by sensitivity analyses using MR-Egger regression, weighted median, and Multiple Effectiveness Residual Sums and Outliers (MR-PRESSO) method.

Cardiovascular Disease 52

Cardiovascular Disease Atrial Fibrillation Aneurysm Heart Failure 52

American College of Cardiology

FEBRUARY 23, 2024

What is the prevalence of subclinical atrial fibrillation (AF) in patients with heart failure and preserved ejection fraction (HFpEF), and how does it impact outcomes?

Atrial Fibrillation 65

Atrial Fibrillation Preserved Ejection Fraction Heart Failure Outcomes 65

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

Atrial Fibrillation 64

Atrial Fibrillation Cardiomyopathy Ablation Heart Failure 64

Frontiers in Cardiovascular Medicine

JANUARY 28, 2024

Introduction A high recurrence rate of atrial fibrillation was monitored after catheter ablation for persistent atrial fibrillation. The primary outcome will be sinus rhythm maintenance rate over 12 months, monitored by random electrocardiogram and 24-h Holter electrocardiogram.

Atrial Fibrillation 64

Atrial Fibrillation Heart Failure Ablation Electrocardiogram 64

American College of Cardiology

FEBRUARY 19, 2025

Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heart failure (HF) hospitalization and atrial fibrillation (AFib) recurrence.

AFIB 67

AFIB Ablation Atrial Fibrillation Outcomes 67

Frontiers in Cardiovascular Medicine

JANUARY 28, 2024

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) have emerged as major age-related epidemics within cardiology. Indeed, these two conditions are commonly found in the same individual, so much so that AF has been used in proposed diagnostic criteria for HFpEF.

Preserved Ejection Fraction 59

Preserved Ejection Fraction Heart Failure Atrial Fibrillation Electrophysiology 59

HeartRhythm

MARCH 31, 2025

Rapid lidocaine administration can cause dose-dependent reductions in ventricular contractility, arterial pressure, and heart rate (HR). In patients with heart failure (HF), atrial fibrillation (AF) is common and can further compromise hemodynamic and electrical stability.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Arrhythmia Outcomes 40

European Journal of Heart Failure

NOVEMBER 26, 2024

Discontinuation and reinitiation of mineralocorticoid receptor antagonists (MRA) in patients with heart failure and reduced ejection fraction (HFrEF). BMI, body mass index; eGFR, estimated glomerular filtration rate; NYHA, New York Heart Association. 1.38), a diagnosis of atrial fibrillation (HR 1.24, 95% CI 1.10–1.39),

Heart Failure 71

Heart Failure Kidney Disease BMI Atrial Fibrillation 71

Frontiers in Cardiovascular Medicine

APRIL 2, 2025

BackgroundThe role of the triglyceride-glucose (TyG) index in critically ill patients with congestive heart failure (CHF) and atrial fibrillation (AF), requiring intensive care unit (ICU) admission, remains unclear. The primary outcome was hospital all-cause mortality.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure ICU Hospital 52

HeartRhythm

MAY 22, 2024

The combined effect of left ventricular ejection fraction (LVEF) and atrial fibrillation (AF) on clinical outcomes in heart failure (HF) remains complex.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Outcomes 40

HeartRhythm

JANUARY 6, 2025

Atrial fibrillation (AF) is a common arrhythmia in patients with heart failure (HF). The coexistence of these conditions can further induce structural changes and result in worsened outcomes such as stroke, HF decompensation, poorly controlled AF, and mortality [1].

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Atrial Fibrillation Ablation 40

HeartRhythm

MARCH 31, 2025

Patients with heart failure (HF) and atrial fibrillation (AF) frequently undergo catheter ablation to maintain sinus rhythm and improve cardiovascular outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Hospital 40

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) and heart failure (HF) often coexist and are associated with significant morbidity and mortality.

Heart Failure 40

Heart Failure Atrial Fibrillation Ablation Outcomes 40

HeartRhythm

MARCH 31, 2025

The concept of a 3-month blanking period after catheter ablation (CA) for atrial fibrillation (AF) is widely accepted. However, in AF patients with heart failure (HF), EPR might adversely affect outcomes, though the details remain unclear.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

The combined effect of Left Ventricular Ejection Fraction (LVEF) and the presence of Atrial Fibrillation (AF) on clinical outcomes in heart failure (HF) patients remains complex.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Outcomes 40

HeartRhythm

AUGUST 18, 2024

The impact of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on atrial fibrillation (AF) recurrence outcomes and adverse cardiovascular outcomes in heart failure (HF) patients after AF ablation is unknown.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HeartRhythm

MARCH 31, 2025

Roughly half of patients with heart failure (HF) have preserved ejection fraction (HFpEF). HFpEF and atrial fibrillation (AF) often coexist and share similar risk factors.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Risk Factors 40

Open Heart

AUGUST 10, 2023

Background Atrial fibrillation (AF) is common in individuals with heart failure (HF). A statistically significant improvements in exercise capacity, heart disease QoL, anxiety and depression scores were observed within each group. Evidence supported the effect of exercise training in individuals with HF.

Cardiac Rehabilitation 52

Cardiac Rehabilitation Atrial Fibrillation Heart Failure Quality of Life 52

Heart BMJ

OCTOBER 10, 2024

The term ‘epidemic’ is increasingly used to describe the rising global prevalence of atrial fibrillation (AF). Indeed, numerous studies are currently investigating the impact of such approaches on clinical outcomes and healthcare utilisation. Recent estimates suggest that AF accounts for between 0.9% 2 Before the.

Risk Factors 59

Risk Factors Atrial Fibrillation Kidney Disease Heart Failure 59

HeartRhythm

OCTOBER 21, 2024

Clinical outcomes among patients with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) treated with catheter ablation (CA) versus antiarrhythmic therapy (AAT) are not well-known.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

MARCH 31, 2025

Studies have shown detrimental effects of atrial fibrillation (AF) occurrence among patients with heart failure (HF) with a preserved ejection fraction (HFpEF). Ablative therapy may counter this risk, but the impact of timing of ablation in paroxysmal vs. persistent AF is unclear.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

European Journal of Heart Failure

FEBRUARY 5, 2025

Methods and results TRED-HF was a randomized trial investigating heart failure therapy withdrawal in patients with recovered DCM over 6months. Clinical outcomes are reported in a non-randomized fashion from enrolment and from the end of the trial.

Heart Failure 67

Heart Failure Cardiomyopathy Atrial Fibrillation Arrhythmia 67

HeartRhythm

MARCH 31, 2025

Catheter ablation of atrial fibrillation (AF) is the preferred strategy for improving survival and reducing heart failure (HF) hospitalizations in patients with heart failure with reduced ejection fraction (HFrEF) and AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Outcomes 40

Journal of Cardiovascular Electrophysiology

AUGUST 7, 2023

Abstract A vast amount of now well-established clinical and epidemiological data indicates a close, interdependent, and symbiotic association between atrial fibrillation (AF) and heart failure (HF). Both AF and HF, when co-exist in a patient, have serious treatment and prognostic implications.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HeartRhythm

MAY 2, 2024

The authors claim that their score identifies heart failure (HF) patients who benefit the most from atrial fibrillation (AF) ablation. More than identifying patients who benefit from the ablation, the score seems to identify patients who will have worse outcomes, irrespective of the treatment strategy.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

Leukocyte telomere length (LTL) is a well-established biomarker linked to cardiovascular disease, with shorter LTL associated with increased severity of heart failure (HF) outcomes. It is also well known that atrial fibrillation (AF) and HF are closely related and often coexist.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Biomarkers Cardiovascular Disease 40

HeartRhythm

MARCH 31, 2025

While prior studies have shown regional disparities in patients with myocardial infarction and heart failure within a universal health care, there are very limited data on the association between different regions within a universal health care and access to care and outcomes after atrial fibrillation (AF) diagnosis.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Outcomes Heart Failure 40

HeartRhythm

APRIL 30, 2024

Studies have suggested that early atrial fibrillation (AF) ablation is associated with improved outcomes. However, it is unknown whether these patterns hold for persistent AF among patients with heart failure with preserved ejection fraction (HFpEF). The majority of these studies evaluated paroxysmal AF cases.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) is associated with stroke, heart failure and mortality. Early detection and intervention reduces the risk of adverse outcomes. Artificial-intelligence enhanced electrocardiography (AI-ECG) is a relatively new and promising methodology for the prediction of incident atrial fibrillation.

Atrial Fibrillation 40

Atrial Fibrillation Biomarkers Heart Failure Stroke 40

HeartRhythm

APRIL 30, 2024

Catheter ablation (CA) for atrial fibrillation (AF) and heart failure with reduced ejection fraction <40% (HFrEF) is associated with improved outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Quality of Life 40

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) is highly prevalent among patients with heart failure; however, limited data are available on the effects of cardiac resynchronization therapy (CRT) in individuals with chronic AF.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Outcomes 40

European Journal of Heart Failure

FEBRUARY 25, 2025

Overview of the study population and effects observed after catheter ablation for atrial fibrillation. Conclusion Atrial fibrillation ablation in end-stage HF leads to a substantial decrease in AF burden, a regression from persistent to paroxysmal AF and notably improved LVEF. PVI, pulmonary vein isolation.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Previous studies have demonstrated significant morbidity and mortality in patients with heart failure (HF) with reduced ejection fraction (HFrEF), particularly with accompanying atrial fibrillation (AF).

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

Journal of Cardiovascular Electrophysiology

MARCH 3, 2025

ABSTRACT Background Atrial fibrillation (AF) recurrence remains a significant challenge in heart failure with reduced ejection fraction (HFrEF) patients undergoing cryoballoon ablation (CBA). This study assesses the impact of SGLT2i on AF recurrence and clinical outcomes in HFrEF patients undergoing CBA.

Heart Failure 40

Heart Failure Atrial Fibrillation Ablation Outcomes 40